Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Rev Endocr Metab Disord. 2020 Oct 10;22(1):17–29. doi: 10.1007/s11154-020-09600-6

Table 2.

Mouse lines with downstream disruption of GH action. Summary of the reported mouse lines with a disruption downstream of GHR that inhibits normal GH signaling. Selected phenotypes are included, such as serum GH and IGF-1 levels, body size and weight, bone growth, insulin sensitivity, reproductive capacity, and cancer incidence. Blank cells indicate parameters that were not reported.

Mouse lines GH level IGF-1 level Body size / Weight Body composition Bone growth Insulin sensitivity Reproductive capacity Cancer incidence Other notes References
JAK2 KO Lethal Erythropoiesis impaired [75]
STAT5b KO ↑ (male only) ↓ (both sexes) ↓ (males only) ↓ adipose tissue ↓ (males only) Poor lactation; deficient pregnancy Varies by genetic background Delay of hair growth; GH pulse-resistant [69, 70, 76, 77]
SOCS2 TG ↓ adipose tissue Fertile [71]
SOCS2 KO ↑ local IGF-1; no difference in serum Thickening of dermis; excessive collagen deposition [78, 79]
ALS KO ↓ serum IGF-1 and IGFBP3 ↓ bone mineral density [80, 81]
IGF-1 KO Below detection limits Infertile High neonatal lethality (less than that of IGFR −/−), only 68% reach adulthood [82, 83]
IGFBP3-KO ↔; ↓ No change at birth; ↑ overall weight ↑ muscle mass; ↓ WAT mass ↑ fasting blood glucose, ↑ insulin, impaired GTT ↑lung cancer progression ↓ plasma TG adiponectin levels;↓ metabolic rate [8486]